Nurix Therapeutics, Inc. Common stock
NRIX Real Time Price USDRecent trades of NRIX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by NRIX's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Cbl inhibitors and compositions for use in adoptive cell therapy Oct. 22, 2024
-
Patent Title: Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof Sep. 17, 2024
-
Patent Title: Cyano cyclobutyl compounds for cbl-b inhibition and uses thereof Jul. 30, 2024
-
Patent Title: Combination therapies with cbl-b inhibitor compounds Jun. 25, 2024
-
Patent Title: 3-substituted piperidine compounds for cbl-b inhibition, and use thereof Apr. 09, 2024
-
Patent Title: Bifunctional compounds for degrading btk via ubiquitin proteosome pathway Jan. 09, 2024
-
Patent Title: Bifunctional compounds for degrading btk via ubiquitin proteosome pathway Nov. 21, 2023
-
Patent Title: Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof Aug. 29, 2023
-
Patent Title: Cyano cyclobutyl compounds for cbl-b inhibition and uses thereof Dec. 20, 2022
-
Patent Title: Bifunctional compounds for degrading btk via ubiquitin proteosome pathway Oct. 25, 2022
-
Patent Title: 3-substituted piperidine compounds for cbl-b inhibition, and use thereof Oct. 11, 2022
-
Patent Title: Substituted benzyl-triazole compounds for cbl-b inhibition, and further uses thereof Aug. 02, 2022
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of NRIX in WallStreetBets Daily Discussion
Recent insights relating to NRIX
Recent picks made for NRIX stock on CNBC
ETFs with the largest estimated holdings in NRIX
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view NRIX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.